Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy.
Karlsdottir, Asa
Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy. [electronic resource] - Acta oncologica (Stockholm, Sweden) 2009 - 874-81 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1651-226X
10.1080/02841860902974159 doi
Adenocarcinoma--blood
Aged
Aged, 80 and over
Androgen Antagonists--therapeutic use
Combined Modality Therapy
Gonadotropin-Releasing Hormone--therapeutic use
Humans
Male
Middle Aged
Neoplasm Staging
Neoplasms, Hormone-Dependent--blood
Prognosis
Prostate-Specific Antigen--blood
Prostatic Neoplasms--blood
Radiotherapy Dosage
Radiotherapy, High-Energy
Risk Factors
Survival Rate
Treatment Outcome
Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy. [electronic resource] - Acta oncologica (Stockholm, Sweden) 2009 - 874-81 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1651-226X
10.1080/02841860902974159 doi
Adenocarcinoma--blood
Aged
Aged, 80 and over
Androgen Antagonists--therapeutic use
Combined Modality Therapy
Gonadotropin-Releasing Hormone--therapeutic use
Humans
Male
Middle Aged
Neoplasm Staging
Neoplasms, Hormone-Dependent--blood
Prognosis
Prostate-Specific Antigen--blood
Prostatic Neoplasms--blood
Radiotherapy Dosage
Radiotherapy, High-Energy
Risk Factors
Survival Rate
Treatment Outcome